3.Clinical analysis of multiple primary carcinomas in colorectal cancer patients.
Chang-hua ZHANG ; Yu-long HE ; Wen-hua ZHAN ; Shi-rong CAI ; Mei-jin HUANG ; Jian-ping WANG ; Jian-jun PENG
Chinese Journal of Gastrointestinal Surgery 2005;8(1):38-40
OBJECTIVETo explore the prevalence, clinical features and prognosis of multiple primary neoplasms in patients with colorectal carcinoma (CRC).
METHODSData of colorectal cancer patients admitted to our hospital from June 1994 to June 2002 were analyzed retrospectively. Patients were divided into multiple-cancer group (MCG) and single- cancer group (SCG). Clinical features and prognosis were compared between two groups.
RESULTSThe incidence of multiple cancers was 7.4 % (83/ 1125). Forty- seven patients had multiple colorectal cancers metachronous CRC(S) in 12 and synchronous CRC(S) in 35. Thirty- six patients 5 patients with synchronous cancers had malignant tumors outside colorectal tract,12 of whom were gastric carcinomas. No significant differences were found between MCG and SCG regarding gender, onset age, Dukes stage and differentiation of index CRC. Cancer family history (P=0.002) and colorectal adenoma (P=0.036) were significantly more common in MCG than those in SCG. The local recurrence or distant metastasis in MCG was significantly higher than that in SCG (P=0.047), though there was no significant difference in survival between the two groups. Forty- one percent of index tumors were located in right colon in MCG, significantly higher than that in SCG (P=0.048). The secondary tumors were mainly adenoma cancerization in MCG.
CONCLUSIONCancer family history and colorectal adenoma seems to be at high risk for developing multiple cancers in CRC patients. Gastric cancer and colorectal adenoma cancerization were common secondary tumors of multiple primary neoplasms in patients with colorectal carcinoma.
Adenomatous Polyps ; genetics ; Adult ; Aged ; Colorectal Neoplasms ; diagnosis ; epidemiology ; pathology ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Staging ; Neoplasms, Multiple Primary ; diagnosis ; epidemiology ; pathology ; Prognosis ; Retrospective Studies ; Risk Factors
4.Characteristics and Survival of Breast Cancer Patients with Multiple Synchronous or Metachronous Primary Cancers.
Janghee LEE ; Seho PARK ; Sanghwa KIM ; Jeeye KIM ; Jegyu RYU ; Hyung Seok PARK ; Seung Il KIM ; Byeong Woo PARK
Yonsei Medical Journal 2015;56(5):1213-1220
PURPOSE: Newly developed extra-mammary multiple primary cancers (MPCs) are an issue of concern when considering the management of breast cancer survivors. This study aimed to investigate the prevalence of MPCs and to evaluate the implications of MPCs on the survival of breast cancer patients. MATERIALS AND METHODS: A total of 8204 patients who underwent surgery at Severance Hospital between 1990 and 2012 were retrospectively selected. Clinicopathologic features and survival over follow-up periods of < or =5 and >5 years were investigated using univariate and multivariate analyses. RESULTS: During a mean follow-up of 67.3 months, 962 MPCs in 858 patients (10.5%) were detected. Synchronous and metachronous MPCs were identified in 23.8% and 79.0% of patients, respectively. Thyroid cancer was the most prevalent, and the second most common was gynecologic cancer. At < or =5 years, patients with MPCs were older and demonstrated significantly worse survival despite a higher proportion of patients with lower-stage MPCs. Nevertheless, an increased risk of death in patients with MPCs did not reach statistical significance at >5 years. The causes of death in many of the patients with MPCs were not related to breast cancer. Stage-matched analysis revealed that the implications of MPCs on survival were more evident in the early stages of breast disease. CONCLUSION: Breast cancer patients with MPCs showed worse survival, especially when early-stage disease was identified. Therefore, it is necessary to follow screening programs in breast cancer survivors and to establish guidelines for improving prognosis and quality of life.
Adult
;
Aged
;
Breast/pathology
;
Breast Neoplasms/diagnosis/*mortality
;
Female
;
Humans
;
Middle Aged
;
Multivariate Analysis
;
Neoplasm Metastasis
;
Neoplasm Staging
;
Neoplasms, Multiple Primary/diagnosis/*mortality
;
Neoplasms, Second Primary/diagnosis/*mortality
;
Prognosis
;
*Quality of Life
;
Republic of Korea/epidemiology
;
Retrospective Studies
;
Survival Analysis
5.Extrapancreatic Tumors in Intraductal Papillary Mucinous Neoplasm of the Pancreas.
Seok Jin OH ; Se Joon LEE ; Hwal Youn LEE ; Yong Han PAIK ; Dong Ki LEE ; Kwan Sik LEE ; Jae Bock CHUNG ; Jeong Sik YU ; Dong Sup YOON
The Korean Journal of Gastroenterology 2009;54(3):162-166
BACKGROUND/AIMS: Intraductal papillary mucinous neoplasm (IPMN) of the pancreas has a favorable prognosis, but seems to be associated with a high incidence of extrapancreatic tumors. The purpose of this study was to evaluate the incidence and clinicopathological features of extrapancreatic tumors associated with IPMN. METHODS: Thirty-seven patients with IPMN of the pancreas, confirmed by surgical resection and typical findings of endoscopic ultrasonography and CT imaging between October 1, 1998 and August 31, 2006 were included. Seventeen patients were diagnosed with surgical resection and biopsy, and others by typical imaging findings of IPMN. These patients were examined for the development of extrapancreatic tumors. RESULTS: Of 37 patients with IPMN, 14 (38%) had 18 extrapancreatic tumors, and 10 (27%) had 13 extrapancreatic malignancies. Five, six, and two extrapancreatic malignancies had diagnosed before during, and after the diagnosis of IPMN. Gastric adenocarcinoma (3 patients, 23%) and colorectal carcinoma (3 patients, 23%) were the most common neoplasms. Other extrapancreatic tumors included lung cancer (n=2), prostatic cancer (n=1), renal cell carcinoma (n=1), cholangiocelluar carcinoma (n=1), urinary bladder cancer (n=1), and gallbladder cancer (n=1), respectively. As benign tumor, there were two gallbladder adenoma, one gastric adenoma, one colonic adenoma and one benign ovarian cystic neoplasm, respectively. CONCLUSIONS: IPMN is associated with high incidence of extrapancreatic tumors, particularly gastric and colorectal neoplasms. Upper gastrointestinal endoscopy and colonoscopy should be done, and systemic surveillance for the possible occurrence of other tumors may allow early detection of extrapancreatic tumor in patients with IPMN.
Adenocarcinoma, Mucinous/*diagnosis/pathology/ultrasonography
;
Adult
;
Aged
;
Aged, 80 and over
;
Carcinoma, Pancreatic Ductal/*diagnosis/pathology/ultrasonography
;
Carcinoma, Papillary/*diagnosis/pathology/ultrasonography
;
Female
;
Humans
;
Incidence
;
Male
;
Middle Aged
;
Neoplasms, Multiple Primary/diagnosis/*epidemiology
;
Neoplasms, Second Primary/diagnosis/*epidemiology
;
Pancreatectomy
;
Pancreatic Neoplasms/*diagnosis/pathology/ultrasonography
;
Retrospective Studies
;
Tomography, X-Ray Computed
6.The advancement of predictive diagnosis and molecular mechanism in multiple primary lung cancer.
Lan YUAN ; Lun-Xu LIU ; Guo-Wei CHE
Chinese Journal of Cancer 2010;29(5):575-578
Due to the advanced diagnostic technique and better understanding for multiple primary lung cancers (MPLC), the increasing incidence of MPLC has been reported. Very often, MPLC are misdiagnosed as metastasis because of lacking efficient molecular biomarkers for prediction and diagnosis. Studies on the molecular mechanism for tumorgenesis and progression of MPLC may therefore facilitate the discovery of biomarkers for disease diagnosis and prognosis, so that an individual and rational treatment can be achieved. We tried to further our understanding and improve the diagnostic skill for MPLC by reviewing the current status and the latest advancement of molecular markers related to MPLC.
Adenocarcinoma
;
pathology
;
Biomarkers, Tumor
;
analysis
;
Carcinoma, Non-Small-Cell Lung
;
drug therapy
;
radiotherapy
;
Carcinoma, Small Cell
;
pathology
;
Carcinoma, Squamous Cell
;
pathology
;
Chromosome Deletion
;
DNA Damage
;
Genes, Tumor Suppressor
;
Humans
;
Incidence
;
Lung Neoplasms
;
diagnosis
;
epidemiology
;
etiology
;
genetics
;
Neoplasms, Multiple Primary
;
diagnosis
;
epidemiology
;
etiology
;
genetics
;
Smoking
;
adverse effects